The global single-cell analysis market is witnessing high growth due to increasing geriatric population, high prevalence of infectious diseases, growing focus on personalized medicines, and technological advancements in single-cell analysis products. The increased use of microfluidics in single-cell analysis instruments is also leading to its higher adoption. Moreover, increasing conferences and meetings of single-cell analysis such as 4th annual single cell analysis congress 2016, and Keystone Symposia Conference: Single Cell Omics - Program, are further promoting the growth of the market. However, high cost of single-cell analysis products and intellectual property right issues restrict innovations in assay kits and are the key restraints associated with the growth of the global market.

On the basis of single-cell analysis instrument, the NGS systems segment held the largest share in the global market in 2015. Among the various type of cell in single-cell analysis, the human cells segment held the largest share in the global market in 2015. The single-cell analysis market globally had largest application in cancer and the largest end users were hospitals and diagnostic laboratories in 2015.

The growing geriatric population across the globe are expected to increase the demand for single-cell analysis products. The geriatric population is more vulnerable to infections and immunological diseases, which is having high positive impact on market growth. According to UN report, the number of people aged 60 years or over is projected to grow by 56% from 901 million in 2015 to reach 1.4 billion, globally by 2030. It further reported that by 2050 the global geriatric population is expected to more than double of its size than in 2015, reaching nearly 2.1 billion. Thus, the growing incidence of geriatric population is driving the growth of this market.

High prevalence of infectious diseases is one of the major factor responsible for the growth of single-cell analysis market such as HIV, HCV etc. For instance, according to Joint United Nations Programme on HIV/AIDS (UNAIDS), approximately 36.7 million people worldwide in 2015 are living with HIV infection. Various research applications in single-cell analysis market helps in deriving different treatment methodologies to treat these infections.

The global single-cell analysis market is segmented on the basis of type of product as consumables and instruments. On the basis of consumables, global single-cell analysis market is segmented into beads, microplates, reagents, assay kits, and others. On the basis of instruments, global single-cell analysis market is segmented into flow cytometers, NGS systems, PCR instruments, microscopes, and Others. The consumables segment is expected to grow at the highest CAGR during 2016-2022. The reagents segment held the largest share in the global market in 2015.

Based on type of cell, market is segmented into human cells, animal cells and microbial cells. Based on type of techniques, market is segmented into flow cytometry, Next-generation sequencing (NGS), polymerase chain reaction (PCR), microscopy, and others. Based on application, market is segmented into research applications and diagnostic applications. The research applications are further segmented into cancer, immunology, neurology, stem cells, and other applications. The diagnostic applications are further segmented into noninvasive prenatal diagnosis (NIPD), In vitro fertilization (IVF), and Circulating tumor cells (CTC’s). And based on type of end users of single-cell analysis, the market is segmented into academic & research institutes, biotechnology and biopharmaceutical companies, hospitals and diagnostic laboratories, and cell banks and IVF centers.

Geographically, North America accounts for the largest single-cell analysis market due to growing aging population and technological advancements in single-cell analysis products. The market is expected to witness fastest growth in Asia during the forecast period, due to the vast awareness from increasing conferences and meetings to market payers and presence of large pool of infection affected patients in this region.

Place An Order

The report will be delivered in PDF format without printing rights. It is recommended for a single user.

USD 5100

Group License

The report will be delivered in PDF format along with the printing rights. It is recommended for up to five users.

USD 6100

Enterprise License

The report will be delivered in PDF format along with printing rights and detailed Excel sheet. It is recommended for organizations where multiple people would like to access the report from multiple locations.